News & Media

News
November 22, 2021
Nationwide Children’s Spinoff Andelyn Biosciences to Open New Lab in Dublin
Media Release
January 13, 2022
COLUMBUS, OH, January 13, 2022 – Andelyn Biosciences, a pioneering cell and gene therapy CDMO born out of Nationwide Children’s Hospital, today...
News
November 22, 2021
Andelyn Biosciences has set its sights on Dublin for one of two new labs for the gene therapy company.
Blog
November 11, 2021
Andelyn Biosciences has established a unique network of industry experts across the entire development and commercialization spectrum. In addition to...
Blog
October 22, 2021
Andelyn Biosciences is building the best cell and gene therapy team in spite of a talent shortage and competitive talent...
News
September 30, 2021
Andelyn Biosciences Inc. is adding a second laboratory in Dublin, and will move into its headquarters in Ohio State University's Innovation District before construction is complete.
Blog
September 23, 2021
The analytical requirements for viral vectors used to deliver gene therapies are complex and constantly evolving. The keys to success,...
Blog
September 16, 2021
The number of gene therapy candidates in development is growing rapidly, with many advancing toward late-stage trials. The majority of...
Media Release
August 25, 2021
TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers.
Blog
August 23, 2021
Abstract: Andelyn Biosciences, a full-spectrum gene therapy CDMO organization that supports clients from preclinical studies through phase III trials, originally...
Blog
June 20, 2021
Adeno-associated viruses (AAV) are small viruses that can infect humans and other primate species. The particularity about AAV is that...